Τελευταία με έπιασε η καταναλωτική μου μανία και αποφάσισα να κάνω ένα κύκλο 2 μηνών με τα παρακάτω προιόντα:
ALRI Jungle Warfare 90 Caps
ALRI Bad Ass Mass 60 Caps
2 x ALRI Pro Anabol 60 Caps
&
ALRI Venom Hyperdrive 3 90 Caps
Εκτός από το πρώτο JW τα υπόλοιπα δεν είναι προορμόνες, αν και για το πρώτο παίζεται μάλλον αντοοιστρογόνο είναι. Δηλαδή πάω για placebo effect στο φουλ.
Το τελευταίο είναι stim/λιποτροπικό.
Θέμα: A.L.R.I.
Εμφάνιση αποτελεσμάτων : 1 έως 15 από 19
-
13-01-09 14:42 #1A.L.R.I.
-
-
13-01-09 15:42 #3
- Εγγραφή
- 07-11-2007
- Περ.
- Natural World
- Μηνύματα
- 776
οντως κρατα ενα log..εχεις το γνωθις αυτων παντως! τα φοβαμαι πολυ τα προορμουνουχα..για μενα καλυτερα ενα λαιτ κυκλο αας!
-
04-03-09 09:24 #4
Μέχρι στιγμής έχω πάρει τα δύο πρώτα ταυτόχρονα και έχω ξεκινήσει το Pro Anabol. Το λιποτροπικό το έδωσα γιατί δεν έχω να χάσω και τίποτε το ιδιαίτερο.
Παράλληλα παίρνω και 3γρ κρεατίνη την ημέρα. Έχω βάλει συνολικά 2 κιλά και δεν βλέπω να βάζω άλλα (ούτε και θέλω) διατηρώντας το ίδιο πρόγραμμα διατροφής με πριν.
Σε γενικές γραμμές κάνουνε κάποια δουλειά αν και δεν είναι ούτε προορμόνες ούτε αναβολικά.
Από side effects το μόνο που παρατήρησα ήταν ένας πονοκέφαλος κατά την 3-4 ημέρα της χρήσης ο οποίος κράτησε κάτι λιγότερο από 48 ώρες και δεν ξαναπαρουσιάσθηκε.
Η χρήση ήταν 3 JW την ημέρα και 2 BAM. Από τα pro anabol θα πάρω από 3 την ημέρα.
-
04-03-09 10:53 #5
Μάλιστα... η ALRI έχει βγάλει κατά καιρούς ενδιαφέροντα πράγματα. Όπως το restore που είναι πολύ καλά σχεδιασμένο για να σπρώχνει τίς ορμόνες σου μετά από "καταπίεση".
kutsup κράτα μας ενήμερους, εμένα με ενδιαφέρει το θέμα και φαντάζομαι και άλλους. Από δύναμη έχεις δει διαφορά; Παίρνεις και κρεατινη βέβαια, Monohydrate να υποθέσω;
-
04-03-09 13:23 #6Αρχικό μήνυμα απο KontorinisMD
-
05-03-09 00:13 #7
Η ALRI είναι μακράν η πιο βρόμικη και ανέντιμη εταιρεία. Πληροφοριακά το Jungle Warfare πλασάρονταν ως AI ενώ ήταν χείριστη PH(χάσιμο μαλλιών,ατροφία όρχεων κ.τ.λ.), το Venom βρέθηκε να περιέχει απαγορευμένα στεροειδή ενώ τον ιδιοκτήτη της αναζητεί το FDA τουκλαχιστον απ τον Σεπτέμβρη
There is no cure for stupidity
Thermolife International Product Development Manager
-
05-03-09 00:24 #8
^εμένα μου άρεσε το restore πάντως σαν σχεδίαση.
ο ιδιοκτητης της εταιριάς πάντως έχει γράψει πράγματα γύρω από τη χημεία του bodybuilding που τα σέβεται πολύς κόσμος και όσο έχω επαφή με usa τον ακούνε πολύ.
ΜΒΠαναγιώτης Βίτσας
-
05-03-09 00:30 #9Αρχικό μήνυμα απο Muscleboss
-
05-03-09 01:30 #10Αρχικό μήνυμα απο MusclebossThere is no cure for stupidity
Thermolife International Product Development Manager
-
05-03-09 01:40 #11Αρχικό μήνυμα απο Muscleboss
The effects of vitex agnus castus extract and interaction with bromocriptine on luteinizing hormone and testosterone in male mice
S.Nasri, PhD 1 Sh.Orian, PhD 2 A.Haeri Rohani, PhD 3 Gh.Amin, PhD 4 M.A.Naghizadeh, MSc 5.
Assistant professor, Department of Biology, Azad Eslami University Parand branch 1 Full professor, Department of Biology Training & Education University of Tehran 2 Full professor, Department of physiology, Tehran University 3, Assistant professor, Department of pharmacogenozy, Tehran University of Medical Sciences 4, Master of Hematology , Oroomieh Blood Transfusion Organization 5.
ABSTRACT
Introduction: Several clinical studies have confirmed the beneficial effect of plants extracts in the treatment of disorders. The purpose of this study was to evaluate the probable effects of vitex agnus?castus (VAC) on the male reproductive physiology, and also the dopaminergic agonist (Bromocriptine) on male mice.
Methods: In this experimental study, in order to evaluate, the medicinal effects of vitex agnus castus, we used the hydroalcoholic VAC. Extract injection with the following doses: 65, 165, 265,365 and 465 mg/kg; bromocriptine as a dopamine agonist receptor (5,10,20 mg/kg). To study the interaction between VAC. Extract and bromocriptine, we injected the optimum doses of VAC. with bromocriptine at the same time. Intraperitoneal injections were applied in all experiments, once a day for 30 days. The control group remained intact and the sham group received vehicle. After the last injection, we collected the animal blood serums for hormonal assays. For statistical analysis, analysis of variance was used and P<0.05 was considered significant.
Text Box: Correspondence: S.Nasri, PhD. Department of Biology Azad Eslami University parand branch Tehran, Iran Tel: +98 21 8283777 Email: S_nasri2000@yahoo.com
Results: LH and testostrone showed significant decrease in bromocriptine group. VAC. Extract decreased significantly the LH and Testosterone levels. The coadministration of VAC. Extract and bromocriptine decreased LH and testosterone.
Conclusion: These results suggest: Dopamine regulates the gonadotroph ? Leyding cells axis. It appears that VAC. Extract effects through dopaminergic system and other pathways.
Quote:
iii. Human data: In a placebo controlled crossover double-blind study of 20 healthy men,
vitex had different effects on prolactin release at different concentrations. Men
received doses of 120 mg, 240 mg or 480 mg of a special vitex extract (BP1095E1)
daily for 14 days. There was a significant increase in prolactin level in men receiving
the lowest dose, but a slight reduction in prolactin level in those receiving the higher
doses26. There were no significant dose-dependent changes in the 24-hour serum
prolactin profile. The changes that occurred during the treatment period depended on
the baseline prolactin levels of the individual subjects7.
6 μήνες τα έχω ποστάρει και εξακολουθούν να το χρησιμοποιούν ενώ καμία έρευνα ποτέ δεν έδηξε ευεργετικο αποτέλεσμα, τι να πειςThere is no cure for stupidity
Thermolife International Product Development Manager
-
05-03-09 01:53 #12
να πεις ότι ο κόσμος είναι χαζός, ευτυχώς για της εταιρίες
-
05-03-09 03:21 #13Αρχικό μήνυμα απο kutsupΗλιας Τριανταφυλλου
-
05-03-09 09:24 #14Η ALRI είναι μακράν η πιο βρόμικη και ανέντιμη εταιρεία. Πληροφοριακά το Jungle Warfare πλασάρονταν ως AI ενώ ήταν χείριστη PH(χάσιμο μαλλιών,ατροφία όρχεων κ.τ.λ.)
Proprietary Mormordica Chirantia Extract: Using ALRI's specific extraction process, they were able to utilize the insulinogenic and non-androgenic AR agonistic fractions unique to ALRI's proprietary extract of mormordica chirantia. By doing so, ALRI can support the hypertrophic event in lean tissue by these two most important mechanisms.
Conjugated (-) 3,4-divanillyl-tetrahydrofuran: This compound is the result of a series of extraction processes performed upon nettle root. This compound has demonstrated a positive effect on total testosterone to free/active testosterone ratio. Many know of nettle root for its anti-aromatase capacity and studies show its positive effects upon BHP in men.
17a-methyl-5a-dehydro-etiocholane-4,6-dien-3-one-17-ol: This substance is a natural non-androgenic metabolite of ATD with improved oral bioavailability. It is an estrogen modulating metabolite that controls, but not annihilates estrogen. This results in optimal muscle growth and a positive impact on libido, while limiting the negative side effects.
Proprietary Conjugated Coleonol Extract: This extract supports AR receptor health to keep receptors operating properly for maximal hypertrophic-type receptor health.
-
05-03-09 18:18 #15
FDA Warns Consumers Against Dietary Supplement Containing Undeclared Drug
Product poses safety risk
The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine. Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug that poses potential safety risks.
"Sibutramine is the active ingredient in an FDA-approved prescription drug used as an appetite suppressant for weight loss," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. "But when present in a dietary supplement, it may harm unsuspecting consumers because sibutramine can substantially increase blood pressure and heart rate (pulse), and may present a significant risk for people with a history of heart disease, heart failure, irregular heart beats or stroke."
Venom HYPERDRIVE 3.0 is marketed by Applied Lifescience Research Industries Inc. (ALR Industries), Oak View, Calif. On Dec. 24, 2008, ALR Industries initiated a recall of all lots of Venom HYPERDRIVE 3.0 after the FDA laboratory analysis showed samples of the product contained undeclared sibutramine. Although ALR Industries claims on its Web site that only "trace amounts" of sibutramine were found in this product, the FDA laboratory tests showed that Venom HYPERDRIVE 3.0 contains a significant amount of sibutramine per dosage unit.
The product was sold via distributors and in retail stores nationwide as well as in Canada, Poland, Sweden, Hungary, South Africa, the Netherlands, Australia, France and the United Kingdom. The product was packaged in red plastic bottles containing 90 capsules each with the UPC# 094922534743.
Consumers who have this product should stop taking it immediately and contact their health care professional if they have experienced any adverse effects. Consumers can contact the company at legal@alrindustries.com to receive further instructions for returning the product and to ask any questions.
Health care professionals and consumers may report serious adverse events (side effects) or product quality problems with the use of this product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or phone.
* Online: MedWatch Online Adverse Event Reporting
* Regular Mail: use postage-paid FDA form 3500 available at: MedWatch - Download reporting forms and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
* Fax: (800) FDA-0178
* Phone: (800) FDA-1088
FDA notified consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement but containing sibutramine, an undeclared drug product and a controlled substance with risks for abuse or addiction. When present in a dietary supplement, it may harm unsuspecting consumers because sibutramine can substantially increase blood pressure and heart rate, and may present a significant risk for people with a history of heart disease, heart failure, irregular heart beats or stroke. The product was sold via distributors and in retail stores nationwide and was packaged in red plastic bottles containing 90 capsules each with the UPC# 094922534743. Consumers who have this product should stop taking it immediately and contact their health care professional if they have experienced any adverse effects.
Read the MedWatch 2009 safety summary, including a link to the FDA News Release, at:
http://www.fda.gov/medwatch/safety/2...ty09.htm#Venom
Akiro den ixe steroidi to venom apla ena xiristo farmakeftiko antioreksiogonoThere is no cure for stupidity
Thermolife International Product Development Manager